Epigenetic effects of cannabis: A systematic scoping review of behavioral and emotional symptoms associated with cannabis use and exocannabinoid exposure

Autores da FMUP
Participantes de fora da FMUP
- Machado, Ana Sofia
- Braganca, Miguel
Unidades de investigação
Abstract
Background: Recent research suggests that epigenetic modifications may mediate the behavioral effects of cannabis, influencing exocannabinnoids' long term effects in cognitive function and its role in the emergence of psychotic symptoms. Basic procedures: In this systematic scoping review, we assessed the current evidence of epigenetic effects associated with the use of cannabis or exocannabinoid administration and their relationship with behavioral and emotional symptoms. We searched PubMed, Cochrane CENTRAL, and Web of Science, up to January 2022, using the terms ``cannabis'' and ``epigenetics.'' The search yielded 178 articles, of which 43 underwent full article revision; 37 articles were included in the review. Main findings: The gathered evidence included observational cross-sectional studies conducted on human subjects and experimental designs using animal models that conveyed disparity in administration dosage, methods of cannabis use assessment and targeted epigenetic mechanisms. Nine studies performed epigenome-wide analysis with identification of differentially methylated sites; most of these studies found a global hypomethylation, and enrichment in genes related to cellular survival and neurodevelopment. Other studies assessed methylation at specific genes and found that cannabis exposure was associated with reduced methylation at Cg05575921, DNMT1, DRD2, COMT, DLGAP2, Arg1, STAT3, MGMT, and PENK, while hypermethylation was found at DNMT3a/b, NCAM1, and AKT1. Conclusions: The review found evidence of an exocannabinoid-induced epigenetic changes that modulate depressive-anxious, psychotic, and addictive behavioural phenotypes. Further studies will require dosage exposure/administration uniformization and a customized pool of genes to assess their suitability as biomarkers for psychiatric diseases.
Dados da publicação
- ISSN/ISSNe:
- 0376-8716, 1879-0046
- Tipo:
- Article
- Páginas:
- -
- Link para outro recurso:
- www.scopus.com
Drug and Alcohol Dependence Elsevier Ireland Ltd
Documentos
- Não há documentos
Filiações
Keywords
- Cannabis; Epigenetic effect; Behavioral; Emotional; Exocannabinoid exposure
Proyectos asociados
Mind the gap: An insight into the temporal relationship between initiation of cannabis use and onset of psychosis
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
Plasma levels of oleoylethanolamide in patients with feeding and eating disorders
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
Ongoing Clinical Trials with Monoclonal Antibodies in Schizophrenia
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2020
Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
Investigador Principal: Maria Augusta Vieira Coelho
Ensaio Clínico Académico (Eating Disorder) . 2022
Effect of the COVID-19 pandemic in patients with Obsessive-Compulsive Disorder
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
The role of opicapone for the treatment of patients with Parkinson´s Disease: clinical evidence
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2023
O Sistema Endocanabinoide na Patofisiologia da Fibrose Dérmica
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2021
Citar a publicação
Machado AS,Braganca M,Vieira M. Epigenetic effects of cannabis: A systematic scoping review of behavioral and emotional symptoms associated with cannabis use and exocannabinoid exposure. Drug Alcohol Depend. 2024. 263. 111401. IF:4,200. (2).